Buyout Desk
Add-onTuesday, October 20, 2026

Astorg-backed Oxoid Remel to carve out Solabia microbiology unit

Oxoid Remel, a maker of diagnostic consumables and equipment for microbiological testing, will take over the microbiology diagnostics division of fellow Astorg portfolio company Solabia.

Oxoid Remel, a supplier of diagnostic consumables and equipment used in microbiological testing, has agreed to carve out the microbiology diagnostics division of Solabia. Both companies are portfolio companies of the European private equity firm Astorg.

Astorg is the sponsor on both sides of the transaction, with Solabia selling the division to Oxoid Remel. No financial terms were disclosed.

Deal facts

Target
Solabia microbiology diagnostic division
Business
Microbiology diagnostic division of Solabia, a carve-out target supplying diagnostic consumables and equipment
Acquirer
Oxoid Remel
Backed by
Astorg
Seller
Solabia (Astorg portfolio company)
Deal type
Add-on
Status
Announced, not yet closed
Announced
Tuesday, October 20, 2026

Sources

Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.